image credit: Sebastian Rittau / Wikimedia

Bayer To Invest $200M In Pharmaceutical Plant In Costa Rica

Bayer will invest $200 million in a new pharmaceutical plant for the production of long-acting reversible contraceptives in Costa Rica, which will provide access to family planning for more women in low- and middle-income countries. Located in the Coyol Free Zone, in Alajuela, construction is already underway on the state-of-the-art pharmaceutical facility, which is expected to begin production in 2024 and will work in coordination with other Bayer plants around the world.

Read More on Business Facilities Magazine